Centers - POCTRN

Our centers

Atlanta Center for Microsystems Engineered Point-of-Care Technologies

Focus: To develop and translate microsystems-engineered technologies including microchip-enabled devices that include microelectromechanical systems (MEMs)-based sensors, microfluidics, and smartphone-based systems.

Center for Innovation in Point-of-Care Technologies for HIV/AIDS and Emerging Infectious Diseases at Northwestern

Focus: To support the development of a pipeline of Point-of-Care Technologies designed to meet the clinical needs of people who live with HIV/AIDS and emerging infectious diseases in low- and middle-income countries.

Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases

Focus: To develop and test the accuracy, acceptability, and optimal implementation of point-of-care tests for sexually transmitted diseases in diverse care delivery contexts both in the United States and in resource-limited settings.

Center for Advancing Point of Care in Heart, Lung, Blood, and Sleep Diseases

Focus: To support development and testing of promising “late-stage” point of care technologies that can be rapidly deployed to enhance the diagnosis, monitoring, management and/or treatment of heart, lung, blood and sleep disorders.

Center for Point of Care Technologies for Nutrition, Infection, and Cancer in Global Health at Cornell University

Focus: To support development, deployment, clinical validation, and commercialization of point-of-care technologies for nutrition, infection and cancer for global health in locations where access to better diagnostics can have the largest worldwide impact. We focus on technologies that address the primary needs of the most vulnerable in the US and internationally.

The Center for Innovation and Translation of Point of Care Technologies for Equitable Cancer Care

Focus: To accelerate the development and adoption of new technologies that can be used to improve the early detection of cancer in low-resource settings in the United States and globally.

RADx: Rapid Acceleration of Diagnostics

In response to the COVID-19 pandemic, the Rapid Acceleration of Diagnostics (RADx®) initiative was formed to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19.

ABOUT RADx